awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36410268-06A21F8D-6F79-494A-A872-1CEDB766671A
Q36410268-06A21F8D-6F79-494A-A872-1CEDB766671A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36410268-06A21F8D-6F79-494A-A872-1CEDB766671A
Incidence and risk of severe infections associated with aflibercept in cancer patients: a systematic review and meta-analysis
P2860
Q36410268-06A21F8D-6F79-494A-A872-1CEDB766671A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36410268-06A21F8D-6F79-494A-A872-1CEDB766671A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
05c94326b285af20659e3bc49ed3838cf4e69777
P2860
Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial.